Entera Bio's total assets for Q2 2025 were $19.67M, a decrease of -8.95% from the previous quarter. ENTX total liabilities were $2.41M for the fiscal quarter, a 8.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.